Can magnesium supplementation be used to treat vertigo symptoms?

Magnesium for Vertigo: Limited Evidence for Specific Conditions

Magnesium is not a standard or recommended treatment for most causes of vertigo, but may have a role in vestibular migraine as part of a broader prophylactic strategy. The major clinical practice guidelines for common vertigo disorders (Ménière's disease and benign paroxysmal positional vertigo) do not recommend magnesium supplementation 1, 2.

Evidence by Vertigo Type

Ménière's Disease

The 2020 American Academy of Otolaryngology guidelines for Ménière's disease make no mention of magnesium as a treatment option 1. The guideline recommends:

• Acute vertigo attacks: Vestibular suppressants (benzodiazepines, anticholinergics) for limited duration only
• Prevention: Dietary sodium restriction (1500-2300 mg/day), caffeine limitation, and lifestyle modifications
• Chronic management: Diuretics, betahistine, or more invasive interventions

Magnesium is conspicuously absent from the treatment algorithm despite the guideline's comprehensive review of dietary and pharmacological interventions 1.

Benign Paroxysmal Positional Vertigo (BPPV)

The 2017 BPPV guideline similarly does not recommend magnesium 2. Treatment focuses on:

• Canalith repositioning procedures (Epley maneuver)
• Liberatory maneuvers (Semont maneuver)
• Physical therapy approaches

Drug treatments are not recommended for BPPV 2.

Vestibular Migraine: The Exception

For vestibular migraine specifically, magnesium (150 mg) combined with riboflavin, coenzyme Q10, and feverfew showed promising results in a 2024 prospective study 3. This combination therapy demonstrated:

• 44.1% improvement in symptom severity
• 44.9% improvement in symptom frequency
• Good tolerability
• 50% of patients showed meaningful improvement

The evidence here is preliminary but suggests magnesium may be useful as part of a prophylactic regimen for vestibular migraine, not for acute attacks 3, 4. A 2023 review supports magnesium as a first-line prophylactic option alongside lifestyle modifications for migraine-associated vestibular symptoms 4.

Acute Vertigo Treatment

One older study (2004) mentioned intravenous magnesium sulfate for acute spontaneous vertigo to "decrease vestibular damage," but this was a single low-quality reference without supporting evidence 5. This approach is not endorsed by current guidelines and should not be considered standard practice.

Clinical Approach

For undifferentiated vertigo:

1. Establish the specific diagnosis first (Ménière's, BPPV, vestibular migraine, vestibular neuritis, central causes)
2. Do not use magnesium empirically for vertigo symptoms
3. Follow diagnosis-specific treatment algorithms

For vestibular migraine:

1. Start with lifestyle modifications (sleep optimization, hydration, trigger avoidance)
2. Consider magnesium 150 mg combined with riboflavin 200 mg as prophylaxis
3. Reserve prescription prophylactics (tricyclic antidepressants, anticonvulsants, calcium channel blockers) for refractory cases 4

For Ménière's disease:

1. Sodium restriction (1500-2300 mg/day) is the primary dietary intervention 1
2. Magnesium has no established role
3. Use vestibular suppressants only during acute attacks

Important Caveats

• Severe magnesium deficiency can cause cerebellar symptoms including vertigo, ataxia, and nystagmus, but this is a rare metabolic disorder, not a treatment indication 6
• Proton pump inhibitors can cause magnesium deficiency and should be considered in patients with unexplained cerebellar symptoms 6
• The evidence for magnesium in vestibular migraine comes from combination products, making it difficult to isolate magnesium's specific contribution 3

Bottom line: Magnesium supplementation is not indicated for general vertigo treatment. Consider it only for vestibular migraine prophylaxis as part of a combination nutraceutical approach, while following established guidelines for other vertigo etiologies.